Cargando…
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is thought to affect about 1 in 1000 people in the UK. ADPKD causes a progressive decline in kidney function, with kidney failure tending to occur in middle age. Children and young people with ADPKD may not have any symptoms. However they may have...
Autores principales: | Dudley, Jan, Winyard, Paul, Marlais, Matko, Cuthell, Oliver, Harris, Tess, Chong, Jiehan, Sayer, John, Gale, Daniel P., Moore, Lucy, Turner, Kay, Burrows, Sarah, Sandford, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489289/ https://www.ncbi.nlm.nih.gov/pubmed/31039757 http://dx.doi.org/10.1186/s12882-019-1285-2 |
Ejemplares similares
-
European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants
por: Harris, Tess, et al.
Publicado: (2018) -
Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?
por: Walker, Emma Y. X., et al.
Publicado: (2022) -
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013) -
Commentary on the NICE guideline on renal replacement therapy and conservative management
por: Kharbanda, Kunaal, et al.
Publicado: (2021) -
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
por: McEwan, Phil, et al.
Publicado: (2018)